Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02125825 · ClinicalTrials.gov registry record
Ambulatory Parkinson's Disease Dyskinesia Monitor for Drug Therapy Titration
A clinical trial, sponsored by Great Lakes NeuroTechnologies.
- Completed
- Registry status
- 14
- Enrollment target
NCT02125825 is a clinical trial that has completed, run by Great Lakes NeuroTechnologies. The registered enrollment target is 14 participants.
The verdict
NCT02125825 has completed, sponsored by Great Lakes NeuroTechnologies.
- COMPLETED
- Registry status
- 14 participants
- Enrollment target
Study Summary
The objective is to assess a compact, portable, wireless movement disorder system with continuous monitoring capabilities to detect and quantify the severity of levodopa-induced dyskinesia in Parkinson's disease.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 14 participants |
| Start Date | 2014-07 |
| Est. Completion | 2014-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02125825
The ClinicalTrials.gov registry entry for NCT02125825 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 14 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Great Lakes NeuroTechnologies, which has 17 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT02125825 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02125825 about?
NCT02125825 is a clinical study titled "Ambulatory Parkinson's Disease Dyskinesia Monitor for Drug Therapy Titration". The objective is to assess a compact, portable, wireless movement disorder system with continuous monitoring capabilities to detect and quantify the severity of levodopa-induced dyskinesia in Parkinson's disease.
What is the current status of trial NCT02125825?
This trial is currently completed. The enrollment target is 14 participants. The study started on 2014-07. Estimated completion is 2014-12.
Who is sponsoring clinical trial NCT02125825?
This trial is sponsored by Great Lakes NeuroTechnologies, which has 17 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.